1. 首都医科大学附属北京中医医院
2. 贵阳中医学院第二附属医院
3. 首都医科大学附属北京友谊医院
4. 江苏省第二中医院
5. 成都中医药大学附属医院
6. 广州市中西医结合医院
7. 广州医科大学附属第五医院
8. 河北工程大学附属医院
9. 重庆市中医院
10. 武汉市中医医院
11. 湖北省中医院
12. 重庆市涪陵中心医院
13. 深圳市第二人民医院
14. 保定市第二医院
15. 南京市中医院
16. 眉山市中医医院
17. 襄阳市第一人民医院
18. 柳州市中医院
19. 衢州市人民医院
20. 邯郸市中医院
纸质出版:2020
移动端阅览
[1]张声生,吴咏冬,冯培民,黄建伟,沈晨,杨小军,胡运莲,金宇,金小晶,赵詹东,林海,赵琦,郑亮,肖惠珍,郭永泽,李旭成,刘爱民,赵志英,易琼,陈峭,张瑜.藿香正气口服液治疗胃肠型感冒暑湿证的多中心、双盲随机对照临床研究[J].中医杂志,2020,61(11):964-970.
ZHANG Shengsheng, WU Yongdong, FENG Peimin, et al. Clinical Study on the Treatment of Gastrointestinal Flu of Summer-Dampness Syndrome with Huoxiang Zhengqi Oral Liquid (藿香正气口服液) : a Multicentered,Randomized,Placebo-Controlled,Double-Blind Clinical Trial[J]. Journal of Traditional Chinese Medicine2020, 61(11): 964-970.
[1]张声生,吴咏冬,冯培民,黄建伟,沈晨,杨小军,胡运莲,金宇,金小晶,赵詹东,林海,赵琦,郑亮,肖惠珍,郭永泽,李旭成,刘爱民,赵志英,易琼,陈峭,张瑜.藿香正气口服液治疗胃肠型感冒暑湿证的多中心、双盲随机对照临床研究[J].中医杂志,2020,61(11):964-970. DOI: 10.13288/j.11-2166/r.2020.11.011.
ZHANG Shengsheng, WU Yongdong, FENG Peimin, et al. Clinical Study on the Treatment of Gastrointestinal Flu of Summer-Dampness Syndrome with Huoxiang Zhengqi Oral Liquid (藿香正气口服液) : a Multicentered,Randomized,Placebo-Controlled,Double-Blind Clinical Trial[J]. Journal of Traditional Chinese Medicine2020, 61(11): 964-970. DOI: 10.13288/j.11-2166/r.2020.11.011.
目的评价藿香正气口服液治疗胃肠型感冒暑湿证的有效性及安全性。方法采用前瞻性、随机、双盲、安慰剂对照的多中心临床研究方法
将全国20个中心确诊为胃肠型感冒暑湿证的240例患者
随机分为高剂量组、低剂量组及安慰剂组
每组80例。高剂量组口服藿香正气口服液
每次20ml
每日2次;低剂量组口服藿香正口服气液10ml/次+藿香正气口服液模拟剂10ml/次
每日2次;安慰剂组口服藿香正气口服液模拟剂
每次20ml
每日2次。各组疗程均为5天。观察主要疗效指标(第3天痊愈率及疾病痊愈时间)、次要疗效指标(胃肠型感冒症状总积分、中医症状总积分及证候有效率、中医单项症状消失率)及不良反应。结果高、低剂量组与安慰剂组第3天痊愈率分别为72.00%、37.33%、14.29%
组间比较差异有统计学意义(P<0.05)
优效检验比较
组间痊愈率率差的95%CI下限均大于0
优效成立。各组中位疾病痊愈时间分别为2.0天、4.0天、5.0天;治疗3天后胃肠型感冒症状总积分分别为(1.04±1.70)分、(2.70±2.50)分、(3.69±2.65)分;治疗5天后中医症状总积分分别为(0.45±0.96)分、(0.69±1.46)分、(1.39±2.15)分;治疗5天后中医证候有效率分别为100.00%、100.00%、90.91%
以上指标组间比较差异均有统计学意义(P<0.05);同时
在中医单项症状恶心或/和呕吐、肢体困重消失率方面
组间比较差异有统计学意义(P<0.05)。治疗期间
各组均未出现与研究药物相关的不良反应。结论藿香正气口服液可改善胃肠型感冒暑湿证患者的临床症状
缩短病程
且安全性良好。
Objective To evaluate the efficacy and safety of Huoxiang Zhengqi Oral Liquid(藿香正气口服液) in treatment of gastrointestinal flu of summer-dampness syndrome. Methods A prospective randomized
double blinded
placebo-controlled and multicentered clinical trial was conducted in 20 clinical centers in China. The 240 subjects confirmed of summer-dampness syndrome of stomach and intestine type enrolled were randomly divided into 3 groups
with 80 cases in each group. A high dose group treated with Huoxiang Zhengqi Oral Liquid 20 ml
twice a day; a low dose group treated with Huoxiang Zhengqi Oral Liquid 10 ml and Huoxiang Zhengqi Oral Liquid mimetic agent 10 ml
twice a day; and a placebo group treated with Huoxiang Zhengqi Oral Liquid mimetic agent 20 ml
twice a day. All the groups were treated for 5 days. The main efficacy indexes including recovery rate on the third day and the time of disease recovery
the secondary efficacy indexes including total score of gastrointestinal flu symptoms
total score of traditional Chinese medicine(TCM) symptoms and syndrome effectiveness
the disappearance rate of single symptoms of TCM and adverse reactions were observed. Results In the high dose group
low dose group and placebo group
the 3-day cure rates was 72.00%
37.33% and 14.29% respectively. The differences are statistically significant(P<0.05). Compared with the superiority test
the 95% CI lower limit of the difference in recovery rate between the groups was greater than 0
and the superiority was established. The median illness cure-time were 2.0
4.0 and 5.0 days respectively
and the total scores of symptoms after 3-day treatment were 1.04±1.70
2.70±2.50 and 3.69±2.65 respectively; the total scores of TCM symptoms after 5-day treatment were 0.45±0.96
0.69±1.46 and 1.39±2.15 respectively
and the effective rates of TCM symptoms after 5-day treatment were 100.00%
100.00% and 90.91% respectively. The differences of the groups mentioned above were statistically significant(P<0.05). Meanwhile
there were significantly statistical differences in the 3 groups in the disappearance rate of single symptom such as nausea and/or vomiting
body trapped(P<0.05). No related adverse effects were reported in 3 groups during the treatment. Conclusion Huoxiang Zhengqi Oral Liquid can improve the clinical symptom of gastrointestinal type flu of summer-dampness syndrome
shorten the course of disease with high safety.
0
浏览量
489
下载量
3
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号